Clinical Trials

Advanced Solid Tumour

NCT07563738 2026-05-04

TEADCO

GastrointestinalOther solid neoplasmThoracic

229 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Pancreatic Neoplasms

NCT04999969 2026-04-30

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

Phase 2 Active not recruiting

126 enrolled 30 charts

Locally Advanced or Metastatic Solid Tumours

NCT03710876 2026-04-21

INFINITE

Phase 3 Completed

53 enrolled 23 charts

Phase 1 Active not recruiting

Mesothelioma, Malignant

NCT04491942 2026-04-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

74 enrolled

BreastGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

NCT07229586 2025-12-19

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

100 enrolled

Solid Tumor

NCT02611037 2025-12-18

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

34 enrolled 12 charts

Mesothelioma, Malignant, Mesothelioma

NCT05147272 2025-12-05

Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

67 enrolled 22 charts

Adult Solid Tumor

NCT04497116 2025-10-21

TRESR

276 enrolled 33 charts

LymphoidOther solid neoplasm

Advanced Solid Tumor

NCT05279300 2025-08-11

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

Phase 1 Recruiting

480 enrolled

Advanced Solid Tumor

NCT03034304 2025-07-24

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

105 enrolled

Advanced Solid Tumors

NCT03560973 2025-03-13

RAMES

164 enrolled

Mesothelioma

NCT02240238 2025-01-22

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

119 enrolled 24 charts

Solid Tumors

NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

186 enrolled

Advanced Solid Tumor

NCT00483366 2024-09-23

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

13 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT05660616 2024-08-27

Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma

40 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT03421353 2024-08-21

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

76 enrolled

Advanced Solid Tumours

NCT04480372 2024-07-01

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

68 enrolled

Phase 2 Not yet recruiting

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT06446388 2024-06-06

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

360 enrolled

Advanced Solid Tumor

NCT04761601 2024-03-13

First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

32 enrolled

Advanced Solid Tumor

NCT04934514 2024-02-20

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

Phase 1/2 Unknown

97 enrolled

Advanced Solid Tumor

NCT00648648 2023-09-21

MK-1775-001

206 enrolled 40 charts

Solid Tumors

NCT05525247 2023-09-21

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

420 enrolled

Advanced Solid Tumor

NCT06041035 2023-09-18

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

115 enrolled

Solid Tumor

NCT00101283 2023-07-03

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

32 enrolled 8 charts

Mesothelioma, Malignant, Mesothelioma

NCT03577704 2023-04-12

HLX07Ib/II

56 enrolled

Advanced Solid Tumors

NCT04481009 2022-12-12

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

26 enrolled

Advanced Solid Tumors

NCT01573780 2022-08-15

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

21 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT02235688 2022-02-10

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors

30 enrolled

Metastatic Solid Tumors

NCT01063816 2021-08-02

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

79 enrolled

Advanced Solid Tumors

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Phase 1 Unknown

72 enrolled

Solid Tumor

NCT02715531 2021-07-09

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

243 enrolled

Solid Tumor

NCT02533674 2021-06-11

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

57 enrolled 19 charts

Solid Tumors

NCT02303899 2021-01-22

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma

22 enrolled

Mesothelioma, Malignant

NCT01862328 2020-06-22

Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors

64 enrolled 21 charts

Solid Tumors

NCT03920839 2020-04-24

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Phase 1 Withdrawn

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT02157792 2020-04-01

M6620 First in Human Study

200 enrolled

Advanced Solid Tumor

NCT00859469 2019-10-30

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

29 enrolled 12 charts

Mesothelioma

NCT01341457 2019-03-01

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

17 enrolled 16 charts

Solid Tumors

NCT03503604 2018-04-20

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Phase 1 Unknown

18 enrolled

Solid Tumors

NCT00887757 2017-11-21

Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors

46 enrolled

Solid Tumors

NCT01593228 2017-09-19

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Phase 3 Completed

37 enrolled

Solid Tumors

NCT01125891 2017-06-23

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Other neoplasmOther solid neoplasm

39 enrolled

Malignant Neoplasmas

NCT01359696 2017-04-12

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

40 enrolled

Solid Tumor

NCT00571298 2017-01-23

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

141 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT00949949 2017-01-12

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

GastrointestinalGenitourinaryOther solid neoplasm

38 enrolled

Cholangiocarcinoma of the Gallbladder

NCT00017186 2016-12-07

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

69 enrolled

Mesothelioma, Malignant

NCT00008125 2016-01-15

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

25 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00217477 2014-12-09

Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer

34 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004144 2014-04-24

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

36 enrolled